Table 2. Series on the revised articles on ALPPS in hepatocellular carcinoma cirrhosis that included histological features.
| Author | Year | n | Histology | Etiology | Gender | Age | Major morbidity (%) | PHLF (%) | Mortality (%) | Stage liver disease | Volumetric data | Drop out (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vennarecci et al. (52) | 2016 | 8 | 8 cirrhosis | 6 HCV; 2 HBV |
8 M | 65 (36-74) | 20 | 12.5 | 12.5 | 8 child A and MELD 8 [7–9] | 71.1% increase in 8 (7–10 days) | 0 |
| Chan et al. (53) | 2016 | 17 | 9 cirrhosis; 8 chronic disease |
17 HBV | 16 M: 1 F | 62 [50–80] | 11.8 | 0 | 5.9 | – | 38.1% increase in 6 (5–22days) | 0 |
| Serenari et al. (54) | 2016 | 8 | 6 cirrhosis | – | 6 M: 2 F | 56 [36–74] | 12.5 | 37.5 | 60 | 6 Child A and MELD 7 (6-10) | 50% increase [14–178%] | 0 |
| Chan et al. (55) | 2017 | 25 | 13 cirrhosis; 8 chronic disease |
1 HCV; 21 HBV; 3 Steatohepatitis |
23 M: 2 F | 62 [50–80] | 16 | 4 | 8 | – | 18.1% and 11.3% increase in chronic disease; 14 and 11% increase in cirrhosis | 0 |
| Wang et al. (57) | 2017 | 10 | 9 cirrhosis; 1 chronic disease |
10 HBV | 9 M: 1 F | 41 [33–60] | 20 | 0 | 10 | 10 Child A and MELD 7 [0–19] | 47% (40–58%) in 28 days (range, 13–31 days) | 20 |
| Cai et al. (56) | 2017 | 12 | 12 cirrhosis | 10 HBV | 10 M: 2 F | 43 [32–79] | 58.3 | 50 | 50 | 10 Child A, 1 Child B and MELD 8 [7–13] | 38.5% (10.1% to 74.6%) in 10.5 [7–44] days | 16.6 |
| Wang et al. (33) | 2018 | 45 | 13 cirrhosis | 45 HBV | 40 M: 5 F | 52 [24–67] | 15 | 15.5 | 11.1 | Median Child A: 5 [5–6] | Median KGR was 9.6%, in 14 days (range, 7–28 days) | 8.9 |
PHLF, postoperative hepatic liver failure; HBV, hepatitis B virus; HVC, hepatitis C virus; KGR, kinetic growth rate; M, male; F, female.